JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

Search

Rigel Pharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

21.8 3.37

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

20.78

Max

21.91

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+59.35% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-05

Naujienos nuotaikos

By Acuity

25%

75%

48 / 375 reitingas Healthcare

Rigel Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-31 23:56; UTC

Karštos akcijos

Stocks to Watch: Amazon, Bio-Rad, Coinbase, Mercer

2025-07-31 23:48; UTC

Rinkos pokalbiai

Scentre Can Beat Annual Earnings Guidance -- Market Talk

2025-07-31 23:45; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Caution Over Earnings, Domestic Politics -- Market Talk

2025-07-31 23:37; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2025-07-31 23:37; UTC

Rinkos pokalbiai

Gold Steady as Traders Eye Tariff-Deal Developments -- Market Talk

2025-07-31 23:12; UTC

Uždarbis

OCBC: Evolving Trade, Monetary Policies, Persistent Geopolitical Tensions Expected to Weigh on Growth Prospects >O39.SG

2025-07-31 23:10; UTC

Uždarbis

Oversea-Chinese Banking: Declining Interest-Rate Environment Weighed in Net Interest Income >O39.SG

2025-07-31 23:09; UTC

Uždarbis

Oversea-Chinese Banking 2Q Net Interest Income S$2.28B Vs. S$2.43B >O39.SG

2025-07-31 23:08; UTC

Uždarbis

Oversea-Chinese Banking 2Q Total Income S$3.55B Vs. S$3.63B >O39.SG

2025-07-31 23:08; UTC

Uždarbis

Oversea-Chinese Banking 2Q Net S$1.82B Vs. Net S$1.94B >O39.SG

2025-07-31 23:01; UTC

Uždarbis

Amazon Posts Higher Sales, Profit -- 3rd Update

2025-07-31 22:08; UTC

Rinkos pokalbiai
Uždarbis

Amazon CEO Impressed by Deals Signed for Project Kuiper -- Market Talk

2025-07-31 22:02; UTC

Rinkos pokalbiai
Uždarbis

Apple's FY Outlook Shows Sales Growth Won't Last -- Market Talk

2025-07-31 21:57; UTC

Rinkos pokalbiai
Uždarbis

Amazon CEO Sees Strong Early Demand for Alexa+ -- Market Talk

2025-07-31 21:50; UTC

Uždarbis

Amazon Earnings Beat Expectations. Why the Stock Is Falling. -- Barrons.com

2025-07-31 21:43; UTC

Uždarbis

Apple's iPhone Sales Blow Past Estimates as Customers Raced to Beat Tariffs -- 2nd Update

2025-07-31 21:29; UTC

Uždarbis

Amazon to Invest More in Chips, Data Centers Amid Generative AI Opportunity, CFO Says

2025-07-31 21:26; UTC

Uždarbis

Apple Expects Revenue to Grow in Mid- to High-Single Digits in Current Quarter, CFO Says

2025-07-31 21:26; UTC

Uždarbis

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

2025-07-31 21:22; UTC

Uždarbis

Amazon Has Impressive Amount of Agreements for Project Kuiper, CEO Says

2025-07-31 21:19; UTC

Uždarbis

Apple Estimates Tariff Impact to Add $1.1B to Costs in Current Quarter, CEO Says

2025-07-31 21:19; UTC

Uždarbis

Apple Incurred $800M in Tariff-Related Costs in 2Q, CEO Says

2025-07-31 21:14; UTC

Uždarbis

Amazon's AWS is Seeing More Demand Than Supply, CEO Says

2025-07-31 21:12; UTC

Uždarbis

Amazon Saw Record Prime Sign-Ups in 3 Weeks Before Prime Day, CEO Says

2025-07-31 21:10; UTC

Uždarbis

Amazon Just Getting Started on Automation, Robotics to Boost Efficiency, CEO Says

2025-07-31 21:09; UTC

Uždarbis

Amazon Delivered to Prime Members at Record Pace in 2Q, CEO Says

2025-07-31 21:09; UTC

Uždarbis

Amazon CEO Sees Diversity of Sellers as Advantage for Inflation-Weary Consumers

2025-07-31 21:08; UTC

Uždarbis

Apple iPhone Revenue Performance Driven by Popularity of iPhone 16 Family, CEO Says

2025-07-31 21:08; UTC

Uždarbis

Amazon CEO Sees Strong Customer Adoption of Perishables Same-Day Delivery Pilot

2025-07-31 21:05; UTC

Uždarbis

Apple's iPhone Sales Blow Past Estimates as Customers Raced to Beat Tariffs -- Update

Akcijų palyginimas

Kainos pokytis

Rigel Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

59.35% į viršų

12 mėnesių prognozė

Vidutinis 33.48 USD  59.35%

Aukščiausias 57 USD

Žemiausias 20.45 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Rigel Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

1

Pirkti

2

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

48 / 375 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

$